VPL-Y

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameVPL-Y
Drug Alias NamePyruvate dehydrogenase kinase blocker (CardioMetabolics)Pyruvate dehydrogenase kinase blocker (Valens Pharma)Y-compoundCMI-YVPL-Y
ClassificationSmall molecules
Mechanisms of ActionPyruvate dehydrogenase kinase inhibitors
TargetsPyruvate dehydrogenase kinase
Therapy Area/IndicationsDiabetes MellitusMetabolic DiseasesAngina Pectoris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alberta
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesValensUniversity Of Alberta
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusMetabolic DiseasesAngina Pectoris

Other Information

ATC CodeN/A
Related LinksN/A